Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-17

FDA Approved: ASTEPRO ALLERGY — Original Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved ASTEPRO ALLERGY (azelastine hydrochloride) under Bayer HealthCare LLC.'s original NDA, establishing its intranasal antihistamine use for allergic r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASTEPRO ALLERGY (Azelastine hydrochloride)

Snippet

ORIG AP for ASTEPRO ALLERGY (AZELASTINE HCL)